13F Holdings
中文EN

Cormorant Asset Management, LP

BOSTON MA · SEC CIK 0001583977

2026Q22026Q1 9 earlier quarters 🔒
$1.95B2026Q2 reported value
50Positions
59.2%Top 10 weight · largest 11.0%
7 / 9New / sold out
Reported value over time$1.95B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

PRAX 11.0%
BBOT 7.0%
PBLS 6.5%
RAPP 5.7%
ERAS 5.6%
EWTX 5.2%
EYPT 5.1%
ALMS 4.7%
ABVX 4.6%
DNTH 3.7%

2026Q2 top buys estimated at quarter-end value

CLYM New+$27.46M
SYRE New+$19.98M
DFTX New+$18.82M
BHVN Added+$12.65M
ANL Added+$12.42M

2026Q2 top sells estimated at quarter-end value

PRAX Reduced-$82.19M
CENTESSA PHARMAC Sold out-$41.71M
MBX Reduced-$31.46M
EWTX Reduced-$30.47M
MLTX Reduced-$24.82M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
PRAX PRAXIS PRECISION MEDICINES I $214.27M10.98%640,000 -245,500-27.7% -$82.19M Reduced
BBOT BRIDGEBIO ONCOLOGY THERAPEUT $136.23M6.98%17,878,594 00.0% — Unchanged
PBLS PARABILIS MEDICINES INC $126.33M6.47%4,615,612 4,615,612— — First reported
RAPP RAPPORT THERAPEUTICS INC $110.74M5.67%2,657,521 -300,000-10.1% -$12.50M Reduced
ERAS ERASCA INC $109.92M5.63%6,000,000 200,0003.4% $3.66M Added
EWTX EDGEWISE THERAPEUTICS INC $101.98M5.23%2,510,000 -750,000-23.0% -$30.47M Reduced
EYPT EYEPOINT INC $100.10M5.13%7,000,000 -1,265,000-15.3% -$18.09M Reduced
ALMS ALUMIS INC $92.46M4.74%3,285,596 -663,645-16.8% -$18.67M Reduced
ABVX ABIVAX SA $89.95M4.61%675,000 -85,000-11.2% -$11.33M Reduced
DNTH DIANTHUS THERAPEUTICS INC $73.11M3.75%750,000 -200,000-21.1% -$19.50M Reduced
DRUG BRIGHT MINDS BIOSCIENCES INC $63.18M3.24%900,000 -159,331-15.0% -$11.19M Reduced
MLTX MOONLAKE IMMUNOTHERAPEUTICS $62.41M3.20%3,205,433 -1,275,000-28.5% -$24.82M Reduced
BIOA BIOAGE LABS INC $58.59M3.00%2,390,605 -500,000-17.3% -$12.26M Reduced
ORKA ORUKA THERAPEUTICS INC $50.76M2.60%533,340 00.0% — Unchanged
ANL ADLAI NORTYE LTD $45.75M2.34%3,978,229 1,080,37237.3% $12.42M Added
BBIO BRIDGEBIO PHARMA INC $40.96M2.10%550,000 -300,000-35.3% -$22.34M Reduced
TNGX TANGO THERAPEUTICS INC $40.64M2.08%1,300,000 -125,000-8.8% -$3.91M Reduced
BHVN BIOHAVEN LTD $38.84M1.99%2,610,000 850,00048.3% $12.65M Added
AGMB AGOMAB THERAPEUTICS NV $32.00M1.64%2,465,348 00.0% — Unchanged
MBX MBX BIOSCIENCES INC $30.36M1.56%550,000 -570,000-50.9% -$31.46M Reduced
CLYM CLIMB BIO INC $27.46M1.41%2,106,000 2,106,000— $27.46M New
OLMA OLEMA PHARMACEUTICALS INC $26.90M1.38%2,150,000 -1,750,000-44.9% -$21.89M Reduced
DMRA DAMORA THERAPEUTICS INC $26.01M1.33%1,000,000 -525,000-34.4% -$13.66M Reduced
PHVS PHARVARIS N V $25.93M1.33%750,000 -250,000-25.0% -$8.64M Reduced
CRBP CORBUS PHARMACEUTICALS HLDGS $22.00M1.13%2,344,971 00.0% — Unchanged
SYRE SPYRE THERAPEUTICS INC $19.98M1.02%225,000 225,000— $19.98M New
DFTX DEFINIUM THERAPEUTICS INC $18.82M0.96%400,000 400,000— $18.82M New
NAMS NEWAMSTERDAM PHARMA COMPANY $16.95M0.87%500,000 -450,000-47.4% -$15.25M Reduced
ROIV ROIVANT SCIENCES LTD $16.81M0.86%475,000 -275,000-36.7% -$9.73M Reduced
CABA CABALETTA BIO INC $15.55M0.80%5,000,000 -500,000-9.1% -$1.55M Reduced
HLXC HELIX ACQUISITION CORP III $13.81M0.71%1,297,500 00.0% — Unchanged
ASND ASCENDIS PHARMA A/S $13.34M0.68%50,000 -45,000-47.4% -$12.00M Reduced
KLRA KAILERA THERAPEUTICS INC $12.12M0.62%550,000 550,000— — First reported
INSM INSMED INC $8.00M0.41%75,000 -115,000-60.5% -$12.26M Reduced
FTH FAETH THERAPEUTICS INC $7.66M0.39%1,028,242 722,020235.8% $5.38M Added
ELVN ENLIVEN THERAPEUTICS INC $7.61M0.39%150,000 150,000— $7.61M New
TARS TARSUS PHARMACEUTICALS INC $6.29M0.32%100,000 -125,000-55.6% -$7.87M Reduced
— IBIO INC $6.25M0.32%3,570,000 3,570,000— $6.25M New
— CRINETICS PHARMACEUTICALS IN $4.68M0.24%125,000 -125,000-50.0% -$4.68M Reduced
ARQT ARCUTIS BIOTHERAPEUTICS INC $4.59M0.24%175,000 -275,000-61.1% -$7.21M Reduced
ARWR ARROWHEAD PHARMACEUTICALS IN $4.08M0.21%50,000 -50,000-50.0% -$4.08M Reduced
GPCR STRUCTURE THERAPEUTICS INC $4.03M0.21%75,000 -100,000-57.1% -$5.37M Reduced
— RESEARCH ALLIANCE CORP III $3.96M0.20%370,000 370,000— — First reported
COGT COGENT BIOSCIENCES INC $3.87M0.20%100,000 -100,000-50.0% -$3.87M Reduced
ALT ALTIMMUNE INC $3.80M0.19%1,250,000 1,250,000— $3.80M New
AMLX AMYLYX PHARMACEUTICALS INC $3.59M0.18%200,000 -150,000-42.9% -$2.69M Reduced
ODTX ODYSSEY THERAPEUTICS INC $3.27M0.17%175,000 175,000— — First reported
PCVX VAXCYTE INC $2.91M0.15%50,000 -50,000-50.0% -$2.91M Reduced
— BOUNDLESS BIO INC $2.50M0.13%1,000,000 1,000,000— $2.50M New
— QUINCE THERAPEUTICS INC $100,0090.01%5,498 5,498— — First reported
— CENTESSA PHARMACEUTICALS PLC $00.00%0 -1,050,000-100.0% -$41.71M Sold out
MAZE MAZE THERAPEUTICS INC $00.00%0 -750,000-100.0% -$22.39M Sold out
— TERNS PHARMACEUTICALS INC $00.00%0 -300,000-100.0% -$15.82M Sold out
ZURA ZURA BIO LTD $00.00%0 -1,450,000-100.0% -$8.63M Sold out
AXSM AXSOME THERAPEUTICS INC. $00.00%0 -50,000-100.0% -$8.45M Sold out
OLMA OLEMA PHARMACEUTICALS INC Call $00.00%0 -500,000-100.0% -$7.46M Sold out
GLUE MONTE ROSA THERAPEUTICS INC $00.00%0 -400,000-100.0% -$6.58M Sold out
RLYB RALLYBIO CORP $00.00%0 -400,000-100.0% -$3.59M Sold out
— CONTEXT THERAPEUTICS INC $00.00%0 -529,550-100.0% -$1.39M Sold out